Page last updated: 2024-08-23

lovastatin and Meningeal Neoplasms

lovastatin has been researched along with Meningeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, GS; Johnson, MD; Okediji, EJ; Toms, SA; Woodard, A	1

Other Studies

1 other study(ies) available for lovastatin and Meningeal Neoplasms

Article	Year
Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase. Journal of neuro-oncology, 2002, Volume: 56, Issue:2 Topics: Aged; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; MAP Kinase Kinase 1; Meningeal Neoplasms; Meningioma; Mevalonic Acid; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Protein Serine-Threonine Kinases; Tumor Cells, Cultured	2002

Article

Year

Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase.

Journal of neuro-oncology, 2002, Volume: 56, Issue:2

Topics: Aged; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; MAP Kinase Kinase 1; Meningeal Neoplasms; Meningioma; Mevalonic Acid; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Protein Serine-Threonine Kinases; Tumor Cells, Cultured

2002